Maharashtra, India -- (SBWire) -- 08/30/2018 --Hepatitis A Vaccine Market
The research report on Hepatitis A Vaccine Market analyzes the entire production and supply chain of the market and provides data as per the different scenarios. Hepatitis A vaccine is a vaccine which is against the hepatitis A virus. The Hepatitis A vaccine is available for long-term prevention of HAV infection, the Minimum age for HAV vaccination is 1 year.
Get PDF Sample of Report @:
https://www.reportsmonitor.com/request_sample/86403
Scope of the Reports:
Some of the major key players functioning in the Hepatitis A Vaccine Market Report include GSK, Merck, Sanofi, Sinovac, Zhejiang Pukang, Changchun Institute of Biological, Kaketsuken, IMBCA, ChangSheng, Convac among others.
The report also provides regional level market analysis and future outlook for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
Two types of HAV vaccines are currently available internationally:
Formaldehyde-inactivated vaccines: Inactivated HAV vaccines are used in most countries. Monovalent inactivated HAV vaccines are available in pediatric dose (0.5 ml) for children aged 1 year to 15 years, and an adult dose (1 ml).
Live attenuated vaccines (based on H2 or LA-1 HAV strains): These vaccines are manufactured and used mainly in China and sporadically in the private sector in India.
Types: Inactivated Vaccine, Live Attenuated Vaccine
Applications: Government Institution, Private Sector
Get discount on Hepatitis A Vaccine Market Report @:
https://www.reportsmonitor.com/check_discount/86403
This report focuses on the Hepatitis A Vaccine in the global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type, and application. Hepatitis A vaccine is a vaccine which is against the hepatitis A virus. The Hepatitis A vaccine is available for long-term prevention of HAV infection, the Minimum age for HAV vaccination is 1 year.
The classification of Hepatitis A Vaccine includes Inactivated Vaccine, Live Attenuated Vaccine, and the sales proportion of Inactivated Vaccine in 2017 is about 70.8%, and the proportion is increasing trend from 2013 to 2018.
Inactivated vaccines: Inactivated HAV vaccines are used in most countries. Monovalent inactivated HAV vaccines are available in pediatric dose (0.5 ml) for children aged 1 year to 15 years, and an adult dose (1 ml).
Purchase the full Hepatitis A Vaccine Market Report @:
https://www.reportsmonitor.com/report/86403/Global-Hepatitis-A-Vaccine-Market
Global Hepatitis A Vaccine Market 2018-2023 Analysis by Leading Players, Types, Growth Factors, Demand, Opportunities, Current Trends & Predictions
This report focuses on the Hepatitis A Vaccine in the global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type, and application. Hepatitis A vaccine is a vaccine which is against the hepatitis A virus. The Hepatitis A vaccine is available for long-term prevention of HAV infection, the Minimum age for HAV vaccination is 1 year.